201.
Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutations
by Stock, Johanna
Pediatric nephrology (Berlin, West), 2016, Vol.32 (1), p.131-137
202.
Prognosis and management of chronic kidney disease (CKD) at the end of life
by Davison, Rachel
Postgraduate Medical Journal, 2014, Vol.90 (1060), p.98-105
203.
Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease
by Paripovic, Dusan
Pediatric nephrology (Berlin, West), 2012, Vol.28 (2), p.295-303
204.
Intradialytic cycling in children and young adults on chronic hemodialysis
by Paglialonga, Fabio
Pediatric nephrology (Berlin, West), 2013, Vol.29 (3), p.431-438
205.
Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease
by Thethi, Tina K
Journal of diabetes and its complications, 2015, Vol.29 (3), p.433-437
206.
Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: a systematic review and network meta-analysis
by Tsukamoto, Shunichiro
Clinical rheumatology, 2021, Vol.41 (3), p.911-919
207.
Active Vitamin D and Accelerated Progression of Aortic Stiffness in Hemodialysis Patients: A Longitudinal Observational Study
by Fortier, Catherine
American journal of hypertension, 2014, Vol.27 (11), p.1346-1354
208.
Factors influencing choice of renal replacement therapy in European Paediatric Nephrology Units
by Watson, Alan R
Pediatric nephrology (Berlin, West), 2013, Vol.28 (12), p.2361-2368
209.
Short- and Long-Term Effects of Alkali Therapy in Chronic Kidney Disease: A Systematic Review
by Susantitaphong, Paweena
American journal of nephrology, 2012, Vol.35 (6), p.540-547
210.
Long-term safety and tolerability of valsartan in children aged 6 to 17 years with hypertension
by Lou-Meda, Randall
Pediatric nephrology (Berlin, West), 2018, Vol.34 (3), p.495-506
211.
Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5
by Rianthavorn, Pornpimol
Pediatric nephrology (Berlin, West), 2013, Vol.28 (8), p.1261-1266
212.
A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease
by Navaneethan, Sankar D
American journal of nephrology, 2015, Vol.42 (4), p.274-281
213.
Current Concepts and Management Strategies in Chronic Kidney Disease-Mineral and Bone Disorder
by CHAUHAN, Veeraish
Southern medical journal (Birmingham, Ala.), 2012, Vol.105 (9), p.479-485
214.
Medical Neighborhood Model for the Care of Chronic Kidney Disease Patients
by Smith, Zoe G
American journal of nephrology, 2016, Vol.44 (4), p.308-315
215.
Adolescent views on transition in diabetes and nephrology
by Tong, Allison
European journal of pediatrics, 2012, Vol.172 (3), p.293-304
216.
Embryonic Stem Cells-loaded Gelatin Microcryogels Slow Progression of Chronic Kidney Disease
by Geng, Xiao-Dong
Chinese medical journal, 2016, Vol.129 (4), p.392-398
217.
Clinical outcome and its predictors in hemodialysis patients with critical limb ischemia undergoing endovascular therapy
by Kataoka, Shohei
Journal of interventional cardiology, 2017, Vol.30 (4), p.374-381
218.
Effects of telmisartan on proteinuria and systolic blood pressure in dogs with chronic kidney disease
by Miyagawa, Yuichi
Research in veterinary science, 2020, Vol.133, p.150-156
219.
CRIT-LINE: a noninvasive tool to monitor hemoglobin levels in pediatric hemodialysis patients
by Garro, Rouba
Pediatric nephrology (Berlin, West), 2015, Vol.30 (6), p.991-998
220.
Towards microRNA-based therapeutics for diabetic nephropathy
by Alvarez, M. L
Diabetologia, 2012, Vol.56 (3), p.444-456
